Question 1

What is Gilead Sciences's P/S ratio?

Accepted Answer

Gilead Sciences (GILD) P/S ratio is 5.4× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by trailing twelve-month revenue, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/S ratio calculated?

Accepted Answer

P/S = Market Capitalisation ÷ Trailing Twelve-Month (TTM) Revenue, or equivalently Share Price ÷ TTM Revenue Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/S ratio?

Accepted Answer

The price-to-sales (P/S) ratio compares a company's market capitalisation to its trailing twelve-month (TTM) revenue. It is calculated as market cap ÷ TTM revenue (equivalent to share price ÷ TTM revenue per share). Because the denominator (revenue) cannot be negative, P/S is widely used to value unprofitable or pre-profit companies and to make cross-sector comparisons.

Question 4

What is a good P/S ratio for Gilead Sciences?

Accepted Answer

A "good" P/S depends heavily on profit margin and growth: software and other high-margin businesses often command 5–15× sales, while low-margin retailers and commodity producers typically trade below 1×. Compare against sector peers rather than absolute thresholds. For Gilead Sciences specifically, the relevant sector benchmark is the current sector median of 3.5×.

Question 5

Is Gilead Sciences's P/S ratio high or low?

Accepted Answer

Gilead Sciences's P/S ratio of 5.4× is above its own 5-year average of 3.8× and above the sector median of 3.5×. That places the current reading at the 92th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Gilead Sciences's historical P/S ratio range?

Accepted Answer

In the available daily series, Gilead Sciences (GILD) P/S ratio has ranged from a low of 2.7× in 2022 to a high of 27.8× in 2002. The 5-year average is 3.8× and the 5-year median is 3.6×.

Question 7

What was Gilead Sciences's P/S ratio in 2025?

Accepted Answer

Gilead Sciences (GILD) P/S ratio at the end of 2025 was 5.2×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month revenue figure available at that date.

Question 8

Why does Gilead Sciences's P/S ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (revenue). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$152.44B	$29.44B	5.2×	+1.2×	Dec 31, 2025
2024	$115.28B	$28.75B	4.0×	+0.3×	Dec 31, 2024
2023	$101.10B	$27.11B	3.7×	-0.2×	Dec 31, 2023
2022	$107.48B	$27.28B	3.9×	+0.6×	Dec 31, 2022
2021	$91.20B	$27.30B	3.3×	+0.4×	Dec 31, 2021
2020	$73.12B	$24.69B	3.0×	-0.7×	Dec 31, 2020
2019	$82.26B	$22.45B	3.7×	+0.0×	Dec 31, 2019
2018	$80.69B	$22.13B	3.6×	+0.1×	Dec 31, 2018
2017	$93.63B	$26.11B	3.6×	+0.5×	Dec 31, 2017
2016	$94.24B	$30.39B	3.1×	-1.4×	Dec 31, 2016
2015	$145.31B	$32.64B	4.5×	-1.3×	Dec 31, 2015
2014	$141.96B	$24.89B	5.7×	-4.6×	Dec 31, 2014
2013	$115.19B	$11.20B	10.3×	+4.5×	Dec 31, 2013
2012	$55.73B	$9.70B	5.7×	+2.1×	Dec 31, 2012
2011	$30.19B	$8.39B	3.6×	-0.1×	Dec 31, 2011
2010	$29.30B	$7.95B	3.7×	-1.9×	Dec 31, 2010
2009	$38.94B	$7.01B	5.6×	-3.2×	Dec 31, 2009
2008	$46.59B	$5.34B	8.7×	-1.3×	Dec 31, 2008
2007	$42.64B	$4.23B	10.1×	+0.3×	Dec 31, 2007
2006	$29.70B	$3.03B	9.8×	-2.0×	Dec 31, 2006
2005	$23.97B	$2.03B	11.8×	+0.4×	Dec 31, 2005
2004	$15.09B	$1.32B	11.4×	-2.2×	Dec 31, 2004
2003	$11.76B	$867.86M	13.6×	-0.7×	Dec 31, 2003
2002	$6.67B	$466.79M	14.3×	-12.5×	Dec 31, 2002
2001	$6.27B	$233.77M	26.8×	—	Dec 31, 2001


Zimmer Biomet Holdings (ZBH)	2.1×
AptarGroup (ATR)	2.1×
Becton, Dickinson and (BDX)	2.1×
Charles River (CRL)	1.9×
Quest Diagnostics (DGX)	1.9×
IQVIA (IQV)	1.7×
GE HealthCare (GEHC)	1.6×
Labcorp Holdings (LH)	1.6×
HCA Healthcare (HCA)	1.4×
Solventum (SOLV)	1.4×
Viatris (VTRS)	1.1×
Baxter International (BAX)	0.8×
DaVita (DVA)	0.7×
Henry Schein (HSIC)	0.6×
Universal Health Services (UHS)	0.6×
UnitedHealth Group (UNH)	0.5×
Elevance Health (ELV)	0.3×
McKesson (MCK)	0.3×
Cigna (CI)	0.3×
CVS Health (CVS)	0.2×
Cardinal Health (CAH)	0.2×
Cencora (COR)	0.2×
Humana (HUM)	0.2×
Molina Healthcare (MOH)	0.2×
Centene (CNC)	0.1×

P/S Ratio for Gilead Sciences (GILD)

P/S Ratio daily chart for Gilead Sciences (GILD)

Historical P/S Ratio for Gilead Sciences (GILD) from 2001 to 2025

About P/S Ratio at Gilead Sciences (GILD)

Gilead Sciences P/S Ratio by Year

Gilead Sciences P/S Ratio 2025: 5.2×

Gilead Sciences P/S Ratio 2024: 4.0×

Gilead Sciences P/S Ratio 2023: 3.7×

Gilead Sciences P/S Ratio 2022: 3.9×

Gilead Sciences P/S Ratio 2021: 3.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

Gilead Sciences (GILD) Key Financials

P/S Ratio daily chart for Gilead Sciences (GILD)

Historical P/S Ratio for Gilead Sciences (GILD) from 2001 to 2025

About P/S Ratio at Gilead Sciences (GILD)

Gilead Sciences P/S Ratio by Year

Gilead Sciences P/S Ratio 2025: 5.2×

Gilead Sciences P/S Ratio 2024: 4.0×

Gilead Sciences P/S Ratio 2023: 3.7×

Gilead Sciences P/S Ratio 2022: 3.9×

Gilead Sciences P/S Ratio 2021: 3.3×

Sector peers by P/S Ratio — chart

Sector peers by P/S Ratio — table

Frequently asked questions

+What is Gilead Sciences's P/S ratio?

+How is the P/S ratio calculated?

+What is the P/S ratio?

+What is a good P/S ratio for Gilead Sciences?

+Is Gilead Sciences's P/S ratio high or low?

+What is Gilead Sciences's historical P/S ratio range?

+What was Gilead Sciences's P/S ratio in 2025?

+Why does Gilead Sciences's P/S ratio change over time?

Gilead Sciences (GILD) Key Financials